拓新药业 (301089.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(拓新药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年第三季度2025年第二季度2025年第一季度2024年第四季度2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
单季度财务指标:
 单季度每股收益(元) --------1.00--2.00
 单季度销售毛利率(%) 会员可见会员可见会员可见会员可见28.0023.0026.00-41.0028.0037.0083.00
 单季度销售净利率(%) 会员可见会员可见会员可见会员可见-1.00-3.002.00-78.004.005.0055.00
 单季度净资产收益率ROE(%) 会员可见会员可见-会员可见----4.00--20.00
 单季度总资产净利率ROA(%) 会员可见会员可见-会员可见----4.00--16.00
单季度财务摘要:
 单季度营业总收入(元) 会员可见会员可见会员可见会员可见106,997,012.00110,434,198.00108,322,507.0089,382,087.0089,151,675.00105,969,013.00551,007,176.00
 单季度营业总成本(元) 会员可见会员可见会员可见会员可见118,691,712.00119,163,468.00111,604,696.00150,714,508.00110,356,588.00110,798,606.00145,292,582.00
 单季度营业收入(元) 会员可见会员可见会员可见会员可见106,997,012.00110,434,198.00108,322,507.0089,382,087.0089,151,675.00105,969,013.00551,007,176.00
 单季度营业利润(元) 会员可见会员可见会员可见会员可见-6,000,121.00-3,625,545.002,476,875.00-60,212,208.00-15,723,764.00-3,571,658.00401,191,562.00
 单季度利润总额(元) 会员可见会员可见会员可见会员可见-9,563,908.00-3,785,462.002,452,206.00-63,081,740.00-15,969,198.00-3,920,501.00399,504,808.00
 单季度净利润(元) 会员可见会员可见会员可见会员可见-874,456.00-3,847,705.002,068,382.00-70,118,099.003,657,889.005,226,715.00304,306,230.00
 单季度归属母公司股东的净利润(元) 会员可见会员可见会员可见会员可见-874,456.00-3,847,705.002,068,382.00-70,118,099.003,657,889.005,226,715.00304,306,230.00
 单季度经营活动产生的现金流量(元) 会员可见会员可见会员可见会员可见49,169,104.007,814,285.0052,145,491.00-25,638,229.002,876,168.00-56,344,735.00106,060,160.00
 单季度投资活动产生的现金流量(元) 会员可见会员可见会员可见会员可见-23,114,828.00-97,005,369.00106,032,689.00-154,140,640.00199,602,145.00-97,601,949.00-76,467,201.00
 单季度筹资活动产生的现金流量(元) ---会员可见38,768.00--21,624,205.00--60,480,694.00-30,215,833.00
 单季度现金及现金等价物净增加(元) 会员可见会员可见会员可见会员可见25,577,740.00-120,454,071.00158,434,973.00-158,044,941.00202,478,313.00-214,120,132.00-928,468.00

前瞻产业研究院